Comparison of Nebulized Long-Acting Muscarinic Antagonist Revefenacin to Ipratropium in COPD Patients With Acute Respiratory Failure Requiring Mechanical Ventilation: Results of the RARICO Study

Barjaktarevic I, Dartt M, Chen S, Champion D, Mempin R, Dejsatha Y, Van Vleet J, Chang S, Estrada O, Young T, Buhr R, Tashkin D, Bando JM. Comparison of Nebulized Long-Acting Muscarinic Antagonist Revefenacin to Ipratropium in COPD Patients With Acute Respiratory Failure Requiring Mechanical Ventilation: Results of the RARICO Study. Chronic Obstr Pulm Dis. 2026 Oct 20. doi: 10.15326/jcopdf.2026.0804. Epub ahead of print. PMID: 42905895.


Related Posts